Snapshot from Aug 13, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Zoetis Securities Class Action Lawsuit
Regulatory Securities Class Action

Zoetis Securities Class Action Lawsuit

Analysis based on 36 articles · First reported Jun 26, 2026 · Last updated Jul 24, 2026

Sentiment
-40
Attention
3
Articles
36
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The allegations have negatively impacted investor confidence in Zoetis, potentially leading to stock price declines and increased legal costs. The outcome of the lawsuit could result in significant financial penalties and reputational damage for the company.

Animal Health Pharmaceuticals
Event Summary

Multiple law firms (Rosen Law Firm, The Gross Law Firm, The Law Offices of Frank R. Cruz) have filed or announced securities class action lawsuits against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased shares between January 14, 2025 and May 6, 2026. The lawsuits allege that Zoetis made false and misleading statements regarding its Companion Animal products, specifically failing to disclose that: (1) veterinarian prescription growth and adoption of Librela (a canine pain treatment) were sharply weakening due to FDA safety warnings about neurological complications; (2) Simparica Trio was losing market share to a lower-priced competitor; and (3) dermatology products Apoquel and Cytopoint were losing market share to a newly launched competitor. The lead plaintiff deadline is July 27, 2026.

Key Actions
93 Rosen Law Firm filed class action lawsuit Zoetis
87 Bragar Eagel & Squire filed class action lawsuit Zoetis
84 The Law Offices of Frank R. Cruz filed class action lawsuit Zoetis
68 United States — Food and Drug Administration issued safety warnings Zoetis
52 The Law Offices of Frank R. Cruz announced opportunity
30 Rosen Law Firm reminded of deadline
Entities Involved
stock
Zoetis
Zoetis is the defendant in the securities class action, facing allegations of misleading investors about its product performance. The lawsuit could lead to financial damages and reputational harm.
Importance 100.0 Sentiment -60.0
priv
Rosen Law Firm
Rosen Law Firm is one of the law firms representing investors in the class action, reminding shareholders of the lead plaintiff deadline.
Importance 40.0 Sentiment 0.0
priv
The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announced the opportunity for investors to lead the securities fraud class action lawsuit.
Importance 30.0 Sentiment 0.0
per
Philip Kim
Philip Kim is an attorney at Rosen Law Firm providing contact information for investors to join the class action.
Importance 20.0 Sentiment 0.0
per
Lawrence Rosen
Lawrence Rosen is the founding partner of Rosen Law Firm, which is involved in the class action.
Importance 20.0 Sentiment 0.0
per
Frank R. Cruz
Frank R. Cruz is the attorney at The Law Offices of Frank R. Cruz involved in the securities fraud lawsuit.
Importance 20.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The FDA issued safety warnings about neurological complications in dogs from Zoetis' Librela, which contributed to the alleged decline in prescriptions.
Importance 20.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
The SEC is the regulatory body overseeing securities laws; the lawsuit is filed under SEC regulations but the SEC is not directly involved.
Importance 10.0 Sentiment 0.0
exch
New York Stock Exchange
Zoetis is listed on the NYSE under ticker ZTS; the exchange is not directly affected by the lawsuit.
Importance 5.0 Sentiment 0.0
Relationships
Zoetis related ↔ United States — Food and Drug Administration
Zoetis related ↔ United States — United States Securities and Exchange Commission
Rosen Law Firm competitor ↔ The Law Offices of Frank R. Cruz Rosen Law Firm is a prominent plaintiff-side securities litigation firm that directly competes with The Law Offices of F
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm related ↔ Frank R. Cruz
Rosen Law Firm related ↔ United States — Food and Drug Administration
Rosen Law Firm securities litigator ↔ United States — United States Securities and Exchange Commission Rosen Law Firm is a global investor rights law firm specializing in filing class action lawsuits against companies for a
Rosen Law Firm related ↔ New York Stock Exchange
The Law Offices of Frank R. Cruz related ↔ Philip Kim
The Law Offices of Frank R. Cruz related ↔ Lawrence Rosen
The Law Offices of Frank R. Cruz related ↔ Frank R. Cruz
The Law Offices of Frank R. Cruz related ↔ United States — Food and Drug Administration
The Law Offices of Frank R. Cruz related ↔ United States — United States Securities and Exchange Commission
Philip Kim partner ↔ Lawrence Rosen Philip Kim is a partner at Rosen Law Firm, founded and managed by Lawrence Rosen, and he works on securities class actio
+ 10 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.